The clinical significance and costs of herbs and food supplements used by complementary and alternative medicine for the treatment of cardiovascular diseases and hypertension

Journal of Human Hypertension

Volumn 30, Issue 1, 2016, Pages 1-6

  Chrysant, S G ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIHYPERTENSIVE AGENT; ARGININE; ASCORBIC ACID; CARDIOVASCULAR AGENT; CREATINE; CREATININE; FISH OIL; HERBACEOUS AGENT; PYRIDOXINE; RIBOFLAVIN; TAURINE; THIAMINE; UBIDECARENONE;

ALTERNATIVE MEDICINE; CARDIOVASCULAR DISEASE; CHINESE MEDICINE; CONTROLLED CLINICAL TRIAL (TOPIC); CRATAEGUS; CRATAEGUS OXYCANTHA; DIET SUPPLEMENTATION; DRUG COST; DRUG EFFICACY; DRUG SAFETY; GARLIC; GINKGO BILOBA; GLYCYRRHIZA; HEALTH CARE COST; HERB; HUMAN; HYPERICUM PERFORATUM; HYPERTENSION; LEORUNUS HETEROPHYLUS; META ANALYSIS; META ANALYSIS (TOPIC); NONHUMAN; ORIENTAL MEDICINE; PANAX QUINQUEFOLIUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SABAL; SALVIA; SALVIA MILTIORRHIZA; SECONDARY PREVENTION; SERANOA REPENS; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC); CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENT; ECONOMICS; HERBAL MEDICINE; PRODUCT SAFETY;

CARDIOVASCULAR DISEASES; COMPLEMENTARY THERAPIES; CONSUMER PRODUCT SAFETY; DIETARY SUPPLEMENTS; HERBAL MEDICINE; HUMANS; HYPERTENSION;

EID: 84949085031     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2015.42     Document Type: Review

References (60)

1. Barnes PM, Bloom B, Nahin RL. Complementary, and alternative medicine use among adults, and children: United States, 2007. Natl Health Stat Rep 2008; 1-23
2. Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complememtary, and alternative medicine (CAM), and frequency of visits to CAM practitioners. United States, 2007. Natl Health Stat Rep 2009; 1-14
3. Kirk J, Dunker KS. Dietary counseling: the ingredient for successfully addressing the use of herbal supplements, and probiotics in chronic kidney disease. Adv Chronic Kidney Dis 2014; 21: 377-384
4. Glisson JK, Walker LA. How physicians should evaluate dietary supplements. Am J Med 2010; 123: 577-582
5. Yeh GY, Davis RB, Phillips RS. Use of complementary therapies in patients with cardiovascular disease. Am J Cardiol 2006; 98: 673-680
6. Brook RD, Appel LJ, Rubenfire M, Ogedegbe G, Bisognano JD, Elliott WJ, et al. Beyond medications, and diet: alternative approaches to lowering blood pressure. A scientific statement from the American Heart Association. Hypertension 2013; 61: 1360-1383
7. Richardson J. What patients expect from complimentary therapy. A qualitative study. Am J Public Health 2004; 94: 1049-1053
8. Honda K, Jacobson JS. Use of complementary, and alternative medicine among United States adults: The influence of personality, coping strategies, and social support. Prev Med 2005; 40: 46-53
9. Bishop FL, Yardley L, Lewith GT. Why consumers maintain complementary, and alternative medicine use: a qualitative study. J Alt Compl Med 2010; 16: 175-182
10. Mucalo I, Jovanovski E, Rahelic D, Bozikov V, Romic Z, Vuksan V. Effects of American ginseng (Panax quinquafolius L.) on arterial stiffness in subjects with type-2 diabetes, and concomitant hypertension. J Ethnopharmacol 2013; 150: 148-153
11. Jovanovski E, Bateman EA, Bhardwaj J, Faigrieve C, Mucalo I, Jenkins AL, et al. Effect of Rg3-enriched Korean red ginseng (Panax ginseng) on arterial stiffness, and blood pressure in healthy individuals: a randomized-controlled trial. J Am Soc Hypertens 2014; 8: 537-541
12. Stavro PM, Woo M, Heim TF, Leiter LA, Vuksan V. North American ginseng extracts have neutral effects on blood pressure in individuals with hypertension. Hypertension 2005; 46: 406-411
13. Stavro PM, Woo M, Leiter LA, Heim TF, Sievenpiper JL, Vuksan V. Long-term intake of North American ginseng has no effect on 24-h blood pressure, and renal function. Hypertension 2006; 47: 791-796
14. Tachjian A, Maria V, Jahangir A. Use of herbal products, and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol 2010; 55: 515-525
15. Pirotta M, Densley K, Forsdike K, Carter M, Gunn J. St Johns wort use in Australian general practice patients with depressive symptoms: their characteristics, and use of other health services. BMC Copml Alt Med 2014; 14: 204
16. Stage TB, Pedersen RS, Damkier P, Christensen MM, Feddersen S, Larsen JT, et al. Intake of St Johns wort improves the glucose tolerance in healthy subjects that ingest metformin compared to metformin alone. Br J Clin Pharmacol 2014; 79(2)): 298-306
17. Zou QZ, Bi RG, Li JM, Feng JB, Yu AM, Chan HP, Zhen MX. Effect of mother wort on blood hyperviscosity. Am J Clin Med 1989; 17: 65-70
18. Solomon PR, Adams F, Silver A, Zimmer J, DeVeaux R. Ginkgo for memory enhancement: a randomized controlled trial. JAMA 2002; 288: 835-840
19. Xiong X, Liu W, Yang XC, Feng B, Zhang YQ, Li SJ, et al. Ginkgo biloba extract for essential hypertension: a systematic review. Phytomedicine 2014; 15: 1131-1136
20. Brinkley TE, Lovato JK, Arnold AM, Furberg CD, Kuller LH, Burke GL, et al. Effect of ginkgo biloba on blood pressure, and incidence of hypertension in elderly men, and women. Am J Hypertens 2010; 23: 528-533
21. Ried K, Frank OR, Stocks NP, Faller P, Sullivan T. Effect of garlic on blood pressure: A systematic review, and meta-analysis. BMC Cardiovasc Dis 2008; 8: 13
22. Rohner A, Ried K, Sobenin IA, Bucher HC, Nordman AJ. A systematic review, and meta-analysis on the effects of garlic preparations on blood pressure in individuals with hypertension. Am J Hypertens 2014; 28(3): 414-423
23. Gardner CD, Lawson LD, Block E, Chatterjee LM, Kiazand A, Balise RR, et al. Effect of raw garlic vs commercial garlic supplements on plasma lipid concentrations in adults with moderate hypercholesterolemia: a randomized clinical trial. Ann Intern Med 2007; 167: 346-353
24. Rasmussen CB, Glisson JK, Minor DS. Dietary supplements, and hypertension: potential benefits, and precautions. J Clin Hyprtens 2012; 14: 467-471
25. Apitz-Castro R, Cabrera S, Cruz MR, Ledesma E, Jain MK. Effects of garlic extract, and of three pure components isolated from it on human platelet aggregation, arachidonate metabolism, release reaction, and platelet ultrastructure. Thromb Res 1983; 32: 155-169
26. Pitler MH, Guo R, Ernst E. Hawthorn extract for treating chronic heart failure. Cochrane Database Syst Rev 2008, CD005312
27. Tauchert M. Efficacy, and safety of crataegus oxycantha special extract WS1442 in comparison with placebo in patients with chronic stable New York Heart Association class-III heart failure. Am Heart J 2002; 143: 910-915
28. Wang J, Xiong X, Feng B. Effect of crataegus usage in cardiovascular disease prevention: an evidence-based approach. Eviv Based Complement Alternat Med 2013; 2013: 149363
29. Pagano E, Laudato M, Griffo M, Capasso R. Phytotherapy of benign prostatic hyperplasia. A minireview. Phytother Res 2014; 28: 949-955
30. Bressler R. Herb-drug interactions: interactions between saw palmetto, and prescription medications. Geriatrics 2005; 60: 32-34
31. Cheng TO. Cardiovascular effects of danshen. Int J Cardiol 2007; 121: 9-22
32. Kang DG, Yun YG, Ryoo JH, Lee HS. Antihypertensive effect of water extract of danshen on renovascular hypertension through inhibition of the renin angiotensin system. Am J Clin Med 2002; 30: 87-93
33. Jia Y, Huang F, Zhang S, Leung SW. Is danshen (Salvia miltiorrhiza) dripping pill more effective than isosorbide dinitrate in treating angina pectoris? A systematic review of randomized controlled trials. Inter J Cardiol 2012; 157: 330-340
34. Omar HR, Komarova I, El-Ghonemi M, Fathy A, Rashad R, Abdelmalak HD, et al. Licorice abuse: time to send a warning message. Ther Adv Endocrinol Metab 2012; 3: 125-138
35. Robles BJ, Sandoval AR, Dardon JD, Blas CA. Lethal licorice lollies (licorice abuse causing pseudohyperaldosteronism). BMJ Case Rep 2013
36. Eriksson JW, Carlberg B, Hillorn V. Life-threatening ventricular tachycardia due to licorice-induced hypokalemia. J Intern Med 1999; 245: 307-310
37. Bisogni V, Rossi GP, Calo LA. Apparent mineraldocorticoid excess syndrome, an often forgotten or unrecognized cause of hypokalemia, and hypertension: a case report, and appraisal of the pathophysiology. Blood Press 2014; 23: 189-1992
38. Singh RB, Wander GS, Rastogi A, Shukla PK, Mittal A, Sharma JP, et al. Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction. Cardiovasc Drugs Ther 1998; 12: 347-353
39. Morisco C, Trimarco B, Condorelli M. Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study. Clin Invest 1993; 71: S134-S136
40. Hofman-Bang C, Rehnqvist N, Swedberg K, Wiklund I, Astrom H. Coenzyme Q10 as an adjunctive in the treatment of congestive heart failure. J Card Fail 1995; 1: 101-107
41. Watson PS, Scalia GM, Galbraith A, Burstow DJ, Bett N, Aroney CN. Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure. J Am Coll Cardiol 1999; 33: 1549-1552
42. Marcoff L, Thompson PD. The role of coenzyme Q10 in statin-associated myopathy. J Am Coll Cardiol 2007; 49: 2231-2237
43. Bookstaver DA, Burkhalter NA, Hatzigeorgiou C. Effect of coenzyme Q10 supplementation on statin-induced myalgias. Am J Cardiol 2012; 110: 526-529
44. Hathcock JN, Shao A. Risk assessment of coenzyme Q10 (Ubiquinone). Reg Toxicol Pharmacol 2006; 45: 282-288
45. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption, and the risk of coronary artery disease in men. N Engl J Med 1993; 328: 1450-1456
46. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption, and the risk for coronary disease in women. N Engl J Med 1993; 328: 1444-1449
47. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheesman K, Mitchinson MJ. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart AntiOxidant Study (CHAOS). Lancet 1996; 347: 781-786
48. Rapola JM, Virtamo J, Ripatti S, Huttunen JK, Albanes D, Taylor PR, et al. Randomized trial of alpha-tocopherol, and beta-carotine supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997; 349: 1715-1720
49. Duffy SJ, Gokce N, Holbrook M, Huang A, Frei B, Keaney JF Jr, et al. Treatment of hypertension with ascorbic acid. Lancet 1999; 354: 2048-2049
50. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium-dependent vasodilation restoring nitric oxide activity in essential hypertension. Circulation 1998; 97: 2222-2229
51. Allard ML, Jeejeebhoy KN, Sole MJ. The management of conditioned nutritional requirements in heart failure. Heart Fail Rev 2006; 11: 75-82
52. Dinicolantonio JJ, Lavie CJ, Niazi AK, O'Keefe JH, Hu T. Effects of thiamine on cardiac function in patients with systolic heart failure: systematic review, and meta-analysis of randomized, double-blind, placebo-controlled trials. Ochsner J 2013; 13: 495-499
53. Connor SL, Connor WE. Are fish oils beneficial in the prevention, and treatment of coronary artery disease? Am J Clin Nutr 1997; 66: 1020S-1031S
54. Harris WS. Omega-3 fatty acids serum lipoproteins: human studies. Am J Clin Nutr 1997; 65: 1645S-1654S
55. Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993; 88: 523-533
56. Von Schacky C, Angerer P, Korhny W, Theisen K, Mudra H. The effect of dietary omega-3 fatty acids on coronary atherosclerosis: A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999; 130: 554-562
57. Dinicolantonio JJ, Lavie CJ, Fares H, Menezes AR, O'Keefe JH. L-carnitine in the secondary prevention of cardiovascular disease: systematic review, and meta-analysis. Mayo Clin Proc 2013; 88: 544-551
58. McNamara SH. FDA regulation of ingredients in dietary supplements after the passage of the Dietary Supplement Health, and Education Act 1994: an update. Food Drug Law J 1996; 51: 313-318
59. Saper RB, Phillips RS, Sehgal A, Khouri N, Davis RB, Panquin J, et al. Lead, mercury, and arsenic in US-and Indian-manufacrured ayurvedic medicines sold via the Internet. JAMA 2008; 300: 915-923
60. Fortman SP, Burda BU, Senger CA, Lin JS, Whitlock EP. Vitamin, and mineral supplements in the primary prevention of cardiovascular disease, and cancer: an updated systematic evidence review for the US Preventive Services Task Force. Ann Intern Med 2013; 159: 824-834